References:
1. World Health Organization. World malaria report 2022. World Health
Organization; 2022.
2. Altahir O, AbdElbagi H, Abubakr M, Siddig EE, Ahmed A, Mohamed NS.
Blood meal profile and positivity rate with malaria parasites among
different malaria vectors in Sudan. Malaria Journal. 2022;21:124.
3. Ahmed A, Ali Y, Elduma A, Eldigail MH, Mhmoud RA, Mohamed NS, et al.
Unique outbreak of Rift Valley fever in Sudan, 2019. Emerging infectious
diseases. 2020;26:3030.
4. Ahmed A, Ali Y, Mohamed NS. Arboviral diseases: the emergence of a
major yet ignored public health threat in Africa. The Lancet Planetary
Health. 2020;4:e555.
5. Mohamed NS, Osman HA, Muneer MS, Samy AM, Ahmed A, Mohammed AO, et
al. Identifying asymptomatic Leishmania infections in non-endemic
villages in Gedaref state, Sudan. BMC Research Notes. 2019;12:1–7.
6. Yousif A, Siddig EE, Nouh M, Ahmed A. Rift Valley fever and malaria
co-infection: A case report. Clinical Case Reports. 2023;11.
7. Mohamed NS, Ali Y, Muneer MS, Siddig EE, Sibley CH, Ahmed A. Malaria
epidemic in humanitarian crisis settings the case of South Kordofan
state, Sudan. The Journal of Infection in Developing Countries.
2021;15:168–71.
8. Mohamed NS, Ali Albsheer MM, Abdelbagi H, Siddig EE, Mohamed MA,
Ahmed AE, et al. Genetic polymorphism of the N-terminal region in
circumsporozoite surface protein of Plasmodium falciparum field isolates
from Sudan. Malaria journal. 2019;18:1–10.
9. Mohamed NS, AbdElbagi H, Elsadig AR, Ahmed AE, Mohammed YO, Elssir
LT, et al. Assessment of genetic diversity of Plasmodium falciparum
circumsporozoite protein in Sudan: the RTS, S leading malaria vaccine
candidate. Malaria Journal. 2021;20:1–12.
10. Mohamed NS, Abdelbagi H, Osman HA, Ahmed AE, Yousif AM, Edris YB, et
al. A snapshot of Plasmodium falciparum malaria drug resistance markers
in Sudan: a pilot study. BMC Research Notes. 2020;13:1–7.
11. Hemming-Schroeder E, Ahmed A. Anopheles stephensi in Africa: vector
control opportunities for cobreeding An. stephensi and Aedes arbovirus
vectors. Trends in Parasitology. 2022;
12. Elagali A, Ahmed A, Makki N, Ismail H, Ajak M, Alene KA, et al.
Spatiotemporal mapping of malaria incidence in Sudan using routine
surveillance data. Scientific Reports. 2022;12:1–13.
13. Ahmed A, Elduma A, Magboul B, Higazi T, Ali Y. The first outbreak of
dengue fever in Greater Darfur, Western Sudan. Tropical medicine and
infectious disease. 2019;4:43.
14. Lewallen S, Bronzan RN, Beare NA, Harding SP, Molyneux ME, Taylor
TE. Using malarial retinopathy to improve the classification of children
with cerebral malaria. Transactions of the Royal Society of Tropical
Medicine and Hygiene. 2008;102:1089–94.
15. Kochar A, Kalra P, Kochar S, Kochar SK, Kochar D. Retinal
haemorrhage: An unusual presentation of vivax malaria. Journal of Vector
Borne Diseases. 2013;50:321.
16. Maude RJ, Beare NA, Sayeed AA, Chang CC, Charunwatthana P, Faiz MA,
et al. The spectrum of retinopathy in adults with Plasmodium falciparum
malaria. Transactions of the Royal Society of Tropical Medicine and
Hygiene. 2009;103:665–71.
17. Beare NA, Taylor TE, Harding SP, Lewallen S, Molyneux ME. Malarial
retinopathy: a newly established diagnostic sign in severe malaria. The
American journal of tropical medicine and hygiene. 2006;75:790.
18. Mehta U, Allen E, Barnes KI. Establishing pharmacovigilance programs
in resource-limited settings: the example of treating malaria. Expert
review of clinical pharmacology. 2010;3:509–25.
19. Adeel AA, Elnour FAA, Elmardi KA, Abd-Elmajid MB, Elhelo MM, Ali MS,
et al. High efficacy of artemether-lumefantrine and declining efficacy
of artesunate+ sulfadoxine-pyrimethamine against Plasmodium falciparum
in Sudan (2010–2015): evidence from in vivo and molecular marker
studies. Malaria journal. 2016;15:1–13.
20. World Health Organization. Compendium of WHO malaria guidance:
prevention, diagnosis, treatment, surveillance and elimination. World
Health Organization; 2019.